The characteristics of the pharmaceutical and biology are significant!GEM ETF Boshi (159908) share continues to grow!

In the afternoon, the GEM ETF Boshi (159908) fluttered and fell 1.5%slightly. The fund has continued to grow recently and is favored by investors. Ingredient stocks have been divided, Wei Ning's health, national porcelain materials, and Xinwangda rose nearly 2%; Mai Rui medical treatment fell more than 6%, and my martial arts and Changchuan Technology fell nearly 5%.

Donghai Securities stated that after the pharmaceutical biological index created the bottom of the year in April, the sector was shocked at the bottom interval for a long time. Last week, the sector index was close to the early low. After nearly half a year of the bottom of the bottom, the various factor factors of the sector have been fully released, and the peripheral disturbance should not be too pessimistic. Recently, the relevant departments proposed that by 2025, the new sales of innovative products accounted for more than 30%of the increase in the operating income of the pharmaceutical industry, and the strong chain replenishment operation of the pharmaceutical industry chain was carried out to combine various policy documents on encouraging and supporting the development of innovative pharmaceuticals. Showing the country's clear attitude and determination to the innovative development of the pharmaceutical and biological industry, domestic pharmaceutical and biological companies can only continuously improve their strength and international competitiveness through innovation and development. The bottom of the current sector is significant, and it is recommended to focus on high -quality enterprises with strong funding strength and stable fundamentals.

- END -